ASHLEY GARRETT: Open Payments
NPI 1699313387 · MARIANNA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 42 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $159 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $179 |
| Merck Sharp & Dohme LLC | 9 | $169 |
| Organogenesis Inc. | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Amgen Inc. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $31 |
| ABBVIE INC. | 1 | $14 |
Products named: LEQVIO, VERQUVO, FARXIGA, APLIGRAF, PURAPLY WOUND MATRIX, Kerendia, REPATHA, CAPVAXIVE.
Industry payments across FL — which companies pay providers there.
